Mupirocin
- Generic Name
- Mupirocin
- Brand Names
- Bactroban, Centany, Pirnuo
- Drug Type
- Small Molecule
- Chemical Formula
- C26H44O9
- CAS Number
- 12650-69-0
- Unique Ingredient Identifier
- D0GX863OA5
- Background
Mupirocin, formerly termed pseudomonic acid A, is a novel antibacterial agent with a unique chemical structure and mode of action apart from other antibiotic agents. Produced by fermentation using the organism Pseudomonas fluorescens, mupirocin is a naturally-occurring antibiotic that displays a broad-specturm activity against many gram-positive bacteria and...
- Indication
Indicated for the treatment of impetigo and secondary skin infections, leading to traumatic skin lesions, due to Staphylococcus aureus and Streptococcus pyogenes.
- Associated Conditions
- Impetigo, Impetigo caused by Staphylococcus aureus, Impetigo caused by streptococcus pyogenes, Secondary infection Skin infection, Staphylococcus aurea colonization of the nasal passage
- Associated Therapies
- -
Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting
- First Posted Date
- 2013-09-25
- Last Posted Date
- 2013-09-25
- Lead Sponsor
- Horizon Health Network
- Target Recruit Count
- 974
- Registration Number
- NCT01949935
- Locations
- 🇨🇦
New Brunswick Heart Centre, Saint John Regional Hospital, Saint John, New Brunswick, Canada
Evaluation of a Staphylococcus Eradication Protocol for Patients Who Present to the ED With Cutaneous Abscess
- Conditions
- Interventions
- First Posted Date
- 2012-02-23
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Tufts Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01537783
- Locations
- 🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States
Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2017-05-15
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Target Recruit Count
- 47
- Registration Number
- NCT01349192
- Locations
- 🇺🇸
St. Louis Children's Hospital, St. Louis, Missouri, United States
🇺🇸University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸The Children's Hospital, Aurora, Colorado, United States
MESS-study MRSA Eradication Study Skåne
- Conditions
- Interventions
- First Posted Date
- 2011-01-04
- Last Posted Date
- 2017-08-22
- Lead Sponsor
- Region Skane
- Target Recruit Count
- 69
- Registration Number
- NCT01269541
- Locations
- 🇸🇪
Kristianstad hospital, Kristianstad, Skåne, Sweden
🇸🇪Örebro university hospital, Örebro, Sweden
🇸🇪SUS Malmö, Malmö, Skåne, Sweden
Effect of Intranasal Mupirocin on Rate of Staphylococcus Aureus Surgical Site Infection Following Cesarean Sections
- Conditions
- Interventions
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- Hillel Yaffe Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT01152593
- Locations
- 🇮🇱
Hillel Yaffe Medical Center, Hadera, Israel
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2010-05-25
- Lead Sponsor
- University Hospital Muenster
- Target Recruit Count
- 1200
- Registration Number
- NCT00156377
- Locations
- 🇩🇪
Institute of Medical Microbiology, University Hospital of Muenster, Muenster, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.